David Suh

Title: David Suh: Innovator in Antibody Production

Introduction

David Suh is a notable inventor based in Midland Park, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the area of antibody production. His innovative work has led to the development of methods that enhance the efficiency of obtaining antibodies that bind to transmembrane proteins.

Latest Patents

David Suh holds a patent titled "Methods for obtaining antibodies that bind transmembrane proteins and cells that produce the same." This patent discloses methods for obtaining cells that express antibodies that bind transmembrane proteins. It also includes methods for generating antibodies from such cells, antibodies to transmembrane proteins and fragments thereof, and nucleic acids encoding the antibodies. More specifically, the disclosure relates to methods for obtaining antibody-producing cells that express an antibody that binds to a transmembrane protein, utilizing lipid bilayer-membrane scaffold protein complexes to present transmembrane protein antigens to cells. He has 1 patent to his name.

Career Highlights

David Suh is currently employed at Regeneron Pharmaceuticals, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Regeneron has allowed him to contribute to groundbreaking research in the field of therapeutic antibodies.

Collaborations

Throughout his career, David has collaborated with esteemed colleagues, including Gang Chen and Ergang Shi. These collaborations have further enriched his research and development efforts in the biotechnology sector.

Conclusion

David Suh is a prominent figure in the field of biotechnology, with a focus on antibody production. His innovative methods and contributions to Regeneron Pharmaceuticals, Inc. highlight his commitment to advancing medical science. His work continues to have a significant impact on the development of therapeutic solutions.